OnQ Prostate is FDA-cleared post-processing software that supports improved detection of clinically significant prostate cancer.
Leveraging an advanced diffusion MRI technique called Restriction Spectrum Imaging, powered by AI, the software enables faster, more accurate PI-RADS scoring.